首页 | 本学科首页   官方微博 | 高级检索  
   检索      


EZH1 repression generates mature iPSC-derived CAR T cells with enhanced antitumor activity
Institution:1. Stem Cell Program, Boston Children’s Hospital, Boston, MA 02115, USA;2. Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA;3. Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Charlestown, MA 02114, USA;4. Department of Medicine, Harvard Medical School, Boston, MA 02115, USA;5. Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA;6. Harvard-MIT Health Sciences & Technology, Massachusetts Institute of Technology, Cambridge, MA 02142, USA;7. Department of Microbiology, Immunology and Parasitology, Federal University of Santa Catarina, Florianópolis, SC 88040-900, Brazil;8. Graduate Program of Pharmacology, Center for Biological Sciences, Federal University of Santa Catarina, Florianópolis, SC 88040-900, Brazil;9. Division of Hematology/Oncology, Boston Children’s Hospital and Dana Farber Cancer Institute, Boston, MA 02115, USA;10. Developmental and Regenerative Biology Program, Harvard Medical School, Boston, MA 02115, USA
Abstract:
><ol class=
  • Download : Download high-res image (136KB)
  • Download : Download full-size image
  • Keywords:pluripotent stem cells  hematopoietic stem and progenitor cells  T cell differentiation  EZH1  CAR T cells  cancer immunotherapy
    本文献已被 ScienceDirect 等数据库收录!
    设为首页 | 免责声明 | 关于勤云 | 加入收藏

    Copyright©北京勤云科技发展有限公司  京ICP备09084417号